Evaluation of the Effectiveness and Tolerability of Mycophenolate Mofetil and Mycophenolic Acid for the Treatment of Morphea

IMPORTANCE: First-line systemic therapy for morphea includes methotrexate with or without systemic corticosteroids. When this regimen is ineffective, not tolerated, or contraindicated, a trial of mycophenolate mofetil (MMF) or mycophenolic acid (MPA)—referred to herein as mycophenolate—is recommende...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:JAMA Dermatol
Autori principali: Arthur, Megan, Fett, Nicole M., Latour, Emile, Jacobe, Heidi, Kunzler, Elaine, Florez-Pollack, Stephanie, Houser, Jacob, Sharma, Shivani, Prasad, Smriti, Femia, Alisa, Stern, Marleigh J., Pappas-Taffer, Lisa K., Gaffney, Rebecca, Fernandez, Anthony P., Knabel, Daniel, Cardones, Adela Rambi, Leung, Nicole, Laumann, Anne, Yu, Jeong Min, Zhao, Jeffrey, Vleugels, Ruth Ann, Tkachenko, Elizabeth, Lo, Kelly
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Medical Association 2020
Soggetti:
Original Investigation
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7113833/
https://ncbi.nlm.nih.gov/pubmed/32236497
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamadermatol.2020.0035
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi